協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/10/18 | 2,056 | 2,086 | 2,049 | 2,068 | +18 | +0.9% | 617,200 |
| 2018/10/17 | 2,020 | 2,054 | 2,012 | 2,050 | +43 | +2.1% | 1,002,500 |
| 2018/10/16 | 1,997 | 2,012 | 1,993 | 2,007 | +10 | +0.5% | 933,900 |
| 2018/10/15 | 1,993 | 2,015 | 1,990 | 1,997 | -14 | -0.7% | 872,900 |
| 2018/10/12 | 1,982 | 2,022 | 1,980 | 2,011 | +5 | +0.2% | 1,583,600 |
| 2018/10/11 | 2,017 | 2,037 | 1,981 | 2,006 | -54 | -2.6% | 1,501,400 |
| 2018/10/10 | 2,106 | 2,106 | 2,043 | 2,060 | -36 | -1.7% | 800,300 |
| 2018/10/09 | 2,080 | 2,110 | 2,075 | 2,096 | +24 | +1.2% | 1,794,300 |
| 2018/10/05 | 2,031 | 2,081 | 2,027 | 2,072 | +26 | +1.3% | 1,248,900 |
| 2018/10/04 | 2,109 | 2,112 | 2,041 | 2,046 | -48 | -2.3% | 1,198,600 |
| 2018/10/03 | 2,092 | 2,105 | 2,072 | 2,094 | -15 | -0.7% | 1,126,000 |
| 2018/10/02 | 2,133 | 2,160 | 2,105 | 2,109 | -8 | -0.4% | 1,742,100 |
| 2018/10/01 | 2,140 | 2,146 | 2,112 | 2,117 | -12 | -0.6% | 868,900 |
| 2018/09/28 | 2,140 | 2,165 | 2,114 | 2,129 | +35 | +1.7% | 1,530,300 |
| 2018/09/27 | 2,139 | 2,146 | 2,091 | 2,094 | -48 | -2.2% | 1,224,200 |
| 2018/09/26 | 2,099 | 2,144 | 2,094 | 2,142 | +53 | +2.5% | 1,087,400 |
| 2018/09/25 | 2,112 | 2,119 | 2,073 | 2,089 | +5 | +0.2% | 1,111,300 |
| 2018/09/21 | 2,104 | 2,107 | 2,066 | 2,084 | -11 | -0.5% | 1,551,200 |
| 2018/09/20 | 2,105 | 2,115 | 2,079 | 2,095 | -2 | -0.1% | 1,166,700 |
| 2018/09/19 | 2,113 | 2,120 | 2,090 | 2,097 | +18 | +0.9% | 1,087,500 |
| 2018/09/18 | 2,025 | 2,086 | 2,021 | 2,079 | +66 | +3.3% | 970,900 |
| 2018/09/14 | 2,006 | 2,013 | 1,985 | 2,013 | +26 | +1.3% | 1,511,400 |
| 2018/09/13 | 2,030 | 2,032 | 1,985 | 1,987 | -19 | -0.9% | 860,300 |
| 2018/09/12 | 2,014 | 2,016 | 1,991 | 2,006 | -14 | -0.7% | 917,700 |
| 2018/09/11 | 1,998 | 2,030 | 1,998 | 2,020 | +17 | +0.8% | 1,028,000 |
| 2018/09/10 | 2,000 | 2,011 | 1,987 | 2,003 | +10 | +0.5% | 1,221,200 |
| 2018/09/07 | 1,979 | 1,994 | 1,959 | 1,993 | +31 | +1.6% | 1,305,600 |
| 2018/09/06 | 1,959 | 1,975 | 1,948 | 1,962 | -1 | -0.1% | 656,600 |
| 2018/09/05 | 1,980 | 1,980 | 1,956 | 1,963 | -20 | -1% | 683,500 |
| 2018/09/04 | 1,980 | 1,991 | 1,950 | 1,983 | -6 | -0.3% | 774,400 |
| 2018/09/03 | 1,969 | 1,997 | 1,948 | 1,989 | +19 | +1% | 1,029,600 |
| 2018/08/31 | 1,923 | 1,972 | 1,920 | 1,970 | +50 | +2.6% | 1,255,200 |
| 2018/08/30 | 1,974 | 1,976 | 1,919 | 1,920 | -34 | -1.7% | 1,375,900 |
| 2018/08/29 | 1,948 | 1,967 | 1,940 | 1,954 | +20 | +1% | 915,600 |
| 2018/08/28 | 1,958 | 1,960 | 1,924 | 1,934 | -19 | -1% | 1,019,100 |
| 2018/08/27 | 1,935 | 1,957 | 1,927 | 1,953 | +12 | +0.6% | 853,600 |
| 2018/08/24 | 1,942 | 1,946 | 1,930 | 1,941 | +1 | +0.1% | 1,349,300 |
| 2018/08/23 | 1,950 | 1,954 | 1,927 | 1,940 | ±0 | ±0% | 898,500 |
| 2018/08/22 | 1,935 | 1,953 | 1,923 | 1,940 | +11 | +0.6% | 1,111,600 |
| 2018/08/21 | 1,925 | 1,936 | 1,910 | 1,929 | -12 | -0.6% | 831,200 |
| 2018/08/20 | 1,966 | 1,968 | 1,930 | 1,941 | -44 | -2.2% | 1,036,400 |
| 2018/08/17 | 1,995 | 2,012 | 1,976 | 1,985 | +79 | +4.1% | 2,207,000 |
| 2018/08/16 | 1,951 | 1,960 | 1,894 | 1,906 | -65 | -3.3% | 2,093,700 |
| 2018/08/15 | 2,011 | 2,020 | 1,953 | 1,971 | -90 | -4.4% | 1,944,400 |
| 2018/08/14 | 2,060 | 2,067 | 2,047 | 2,061 | +18 | +0.9% | 957,400 |
| 2018/08/13 | 2,078 | 2,082 | 2,043 | 2,043 | -40 | -1.9% | 839,700 |
| 2018/08/10 | 2,109 | 2,110 | 2,077 | 2,083 | -23 | -1.1% | 1,044,600 |
| 2018/08/09 | 2,092 | 2,110 | 2,085 | 2,106 | +6 | +0.3% | 797,800 |
| 2018/08/08 | 2,130 | 2,130 | 2,099 | 2,100 | -51 | -2.4% | 1,079,000 |
| 2018/08/07 | 2,156 | 2,160 | 2,141 | 2,151 | -18 | -0.8% | 628,900 |
1601～
1650
件表示中 / 3699件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,200円 | -3.5% | -11.3% | 2.76% | 19.95倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 134,100円 | +0.9% | +380.2% | 5.82% | 18.47倍 | 1.59倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 218,800円 | +20.9% | +10.6% | 3.02% | 10.34倍 | 1.37倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 366,700円 | +1.7% | -2.9% | 4.36% | 24.06倍 | 1.26倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 149,200円 | +0.6% | +43.3% | 5.36% | 10.46倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
